Endoxifen downregulates AKT phosphorylation through protein kinase C beta 1 inhibition in ERα+ breast cancer
Swaathi Jayaraman(Johns Hopkins University), Matthew P. Goetz(Mayo Clinic in Arizona)
Cited by 10
Related Papers
MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer
|npj Breast Cancer|2019|673